Skip to main content
    H

    Heartbeam Inc (BEAT)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $0.43
    +0.04 (+9.82%)

    Market Cap: $22.64M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(23/36)
    Avg Surprise
    -7.57%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.09
    Range$-0.10 - $-0.08
    3 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.090.0%
    60d ago$-0.09-2.9%
    30d ago$-0.09+3.5%
    7d ago$-0.090.0%
    Current$-0.09
    Revenue Consensus
    $80000
    Range$15000 - $200000
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.07
    Range$-0.10 - $-0.06
    3 analysts
    Revenue Consensus
    $-21420
    Range$-269750 - $390250
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.07---
    Sep 26EST
    		-$-0.09---
    Jun 26
    Reported Aug 13
    		$-0.10$-0.10+0.00%Beat+33.3%
    Mar 26
    Reported May 13
    		$-0.12$-0.13+7.69%Beat+33.3%
    Dec 25
    Reported Mar 12
    		$-0.14$-0.15+9.68%Beat+80.8%
    Sep 25
    Reported Nov 13
    		$-0.15$-0.15+0.00%Beat+21.1%
    Jun 25
    Reported Aug 13
    		$-0.15$-0.16+6.25%Beat+21.1%
    Mar 25
    Reported May 13
    		$-0.18$-0.15-20.00%Miss-5.9%
    Dec 24
    Reported Mar 13
    		$-0.73$-0.17-329.41%Miss-386.7%
    Sep 24
    Reported Nov 7
    		$-0.19$-0.17-11.76%Miss-46.2%
    Jun 24
    Reported Aug 14
    		$-0.19$-0.16-18.75%Miss-18.8%
    Mar 24
    Reported May 9
    		$-0.17$-0.15-13.33%Miss+66.0%
    Dec 23
    Reported Mar 20
    		$-0.15$-0.13-15.38%Miss+66.7%
    Sep 23
    Reported Nov 14
    		$-0.13$-0.13+0.00%Beat+70.5%
    Jun 23
    Reported Aug 10
    		$-0.16$-0.20+20.00%Beat+62.8%
    Mar 23
    Reported May 11
    		$-0.50$-0.33-51.52%Miss-85.2%
    Dec 22
    Reported Mar 16
    		$-0.45$-0.37-21.62%Miss-87.5%
    Sep 22
    Reported Nov 10
    		$-0.44$-0.34-29.41%Miss-37.5%
    Jun 22
    Reported Aug 11
    		$-0.43$-0.27-59.26%Miss-2050.0%
    Mar 22
    Reported May 12
    		$-0.27$-0.19-42.11%Miss-5.7%
    Dec 21
    Reported Mar 24
    		$-0.24$-0.11-118.18%Miss-321.1%
    Sep 21
    Reported Nov 17
    		$-0.32$-0.32+0.00%Beat-171.1%
    Jun 21
    Reported Jul 9
    		$-0.02$0.00N/AMiss-105.7%
    Mar 21
    Reported Jun 30
    		$-0.26$0.00N/AMiss-156.8%
    Dec 20
    Reported Feb 22
    		$-0.06$0.00N/AMiss-111.9%
    Sep 20
    Reported Oct 29
    		$0.45$0.38+18.42%Beat-13.5%
    Jun 20
    Reported Jul 30
    		$0.35$0.16+118.75%Beat-34.0%
    Mar 20
    Reported May 6
    		$0.45$0.43+4.65%Beat+7.1%
    Dec 19
    Reported Feb 26
    		$0.48$0.48+0.00%Beat-14.3%
    Sep 19
    Reported Nov 5
    		$0.52$0.50+4.00%Beat-1.9%
    Jun 19
    Reported Jul 30
    		$0.53$0.45+17.78%Beat+15.2%
    Mar 19
    Reported Apr 25
    		$0.42$0.41+2.44%Beat+7.7%
    Dec 18
    Reported Feb 21
    		$0.56$0.43+30.23%Beat+75.0%
    Sep 18
    Reported Oct 30
    		$0.53$0.32+65.63%Beat+231.3%
    Jun 18
    Reported Jul 25
    		$0.46$0.31+48.39%Beat+100.0%
    Mar 18
    Reported Apr 25
    		$0.39$0.23+69.57%Beat+143.8%
    Dec 17
    Reported Feb 22
    		$0.32$0.24+33.33%Beat+39.1%
    Sep 17
    Reported Nov 7
    		$0.16$0.25-36.00%Miss-
    Jun 17
    Reported Aug 8
    		$0.23$0.21+9.52%Beat-
    Mar 17
    Reported May 3
    		$0.16$0.16+0.00%Beat-
    Dec 16
    Reported Feb 22
    		$0.23$0.18+27.78%Beat-

    Key Metrics

    Valuation
    P/E Ratio-0.85EV/EBITDAN/A
    Price/FCF-1.63xFCF Yield-61.53%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-328.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.66xQuick Ratio3.61x
    Trading Statistics
    Beta-0.77Avg Volume20.23M
    52-Week High$4.0052-Week Low$0.35

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.48
    SMA 20$0.44
    SMA 50$0.46
    SMA 200$0.97
    EMA 10$0.45
    EMA 20$0.45
    EMA 50$0.48
    EMA 200$0.85

    MACD

    Line: -0.00Signal: 0.00Hist: -0.00

    ADX

    ADX: 28.7+DI: 43.0-DI: 25.0

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down44.0
    PSAR$0.85

    Bollinger Bands

    Upper Band$0.59
    Lower Band$0.28
    %B Position7104%(Upper)
    Band Width0.48

    RSI (14-Day)

    Neutral
    48.0

    Momentum Oscillators

    Stoch %K8.9
    Stoch %D10.4
    Williams %R-87.6
    ROC (10d)3.0%
    Momentum0.01
    CCI (20d)-22.0
    MFI (14d)94.3

    Volatility Measures

    ATR (14d)$0.06(14.0%)
    StdDev (20d)0.08
    Hist Vol215.7%(High)

    Volume Flow

    VWAP$0.42
    OBV924.2M
    AD Line-373.7M
    CMF (20d)-0.674

    Volume Metrics

    Avg Vol (20d)22.2M
    Vol Ratio0.1x(Low)
    VWMA (20d)$0.64

    Pivot Points

    R3$0.44
    R2$0.42
    R1$0.41
    Pivot Point$0.39
    S1$0.38
    S2$0.36
    S3$0.35

    Advanced Oscillators

    TSI-0.98
    Ultimate Osc30.7
    KST73.80

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$-8,000$0$0$0$7,000$0$0$0N/A$0
    Gross Profit$0$0$8,000$0$0$0$-7,000$0$0$0N/A$0
    Operating Expenses$5.09M$4.72M$5.31M$5.29M$5.04M$5.50M$4.94M$5.07M$5.09M$4.78M$4.11M$3.74M
    R&D$2.33M$2.37M$3.35M$3.28M$3.33M$3.49M$2.89M$2.89M$2.84M$2.43M$2.01M$1.62M
    SG&A$2.76M$2.35M$1.95M$2.01M$1.71M$2.01M$2.06M$2.18M$2.25M$2.36M$2.10M$2.11M
    Operating Income$-5,092,000$-4,716,000$-5,308,000$-5,290,000$-5,037,000$-5,504,000$-4,944,000$-5,069,000$-5,090,000$-4,784,000$-4,109,000$-3,737,000
    Interest Income$53,000$16,000$3,000$36,000$63,000$20,000$38,000$96,000$134,000$178,000$230,000$267,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-5,039,000$-4,700,000$-5,302,000$-5,255,000$-4,974,000$-5,484,000$-4,907,000$-4,979,000$-4,956,000$-4,606,000$-3,879,000$-3,470,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,039,000$-4,700,000$-5,302,000$-5,255,000$-4,974,000$-5,484,000$-4,907,000$-4,979,000$-4,956,000$-4,606,000$-3,879,000$-3,470,000
    EBITDA$-5,035,000$-4,692,000$-5,291,000$-5,282,000$-5,029,000$-5,497,000$-4,937,000$-5,069,000$-5,090,000$-4,784,000$-4,109,000$-3,737,000
    EBIT$-5,092,000$-4,716,000$-5,308,000$-5,290,000$-5,037,000$-5,504,000$-4,944,000$-5,069,000$-5,090,000$-4,784,000$-4,109,000$-3,737,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BEAT

    News

    HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients

    HeartBeam, Inc. has joined the European EXIT-CVD research consortium, co-funded by the EU Innovative Health Initiative...

    BioSpace•10/15/26•Bullish

    Form 4 Heartbeam Inc For: 10 October By Investing.com

    This article announces the filing of Form 4 for Heartbeam Inc. on October 10. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial...

    Investing.com Canada•10/10/26•Neutral

    Form 4 Heartbeam Inc For: 10 October By Investing.com

    The article, titled "Form 4 Heartbeam Inc For: 10 October," reports on a Form 4 filing for Heartbeam Inc. It includes the stock symbol BEAT, which showed a -1.84% change. The content primarily consists of market data...

    Investing.com South Africa•10/10/26•Neutral

    Form 4 Heartbeam Inc For: 10 October By Investing.com

    This article is a Form 4 filing for Heartbeam Inc. on October 10. It is a brief report published by Investing.com...

    Investing.com Nigeria•10/10/26•Neutral

    HeartBeam (BEAT) grants Ferrari 90,625 special stock units tied to suspended cash retainers.

    HeartBeam, Inc. director Richard Ferrari received two restricted stock unit awards and a stock option on October 2, 2026. The awards include 125,000 annual RSUs, 90,625 special RSUs linked to suspended cash retainers...

    Stock Titan•10/9/26•Neutral

    BEAT Valuation and Fair Value

    P/E
    -0.8x
    P/FCF
    -1.6x
    P/B
    2.8x
    See GNG's fair value

    BEAT Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -328.4%
    FCF yield
    -61.5%

    BEAT Competitors

    CompanyTicker
    TherapeuticsMD IncTXMD
    InspireMD IncNSPR
    Context Therapeutics IncCNTX
    Universe Pharmaceuticals IncUPC
    Galecto IncGLTO
    PAVmed IncPAVM
    Immutep Ltd ADRIMMP
    Cocrystal Pharma IncCOCP

    Sector: Healthcare

    BEAT Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    1
    Hold
    1
    Sell
    0
    Strong Sell
    0

    BEAT Bull Case vs Bear Case

    Bear case

    • BEAT beat EPS estimates in 37.5% of its last 8 reported quarters.

    BEAT Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -42.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.09
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About BEAT

    Does BEAT pay dividends?

    Heartbeam Inc (BEAT) does not currently pay a regular dividend.

    What is BEAT's market cap?

    Heartbeam Inc (BEAT) has a market capitalization of $22.64M with a current stock price of $0.43.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In